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Abstract
Background: Liver fibrosis is a feature in the majority of chronic liver diseases and oxidative stress is considered to be
its main pathogenic mechanism. Antioxidants including vitamin E, are effective in preventing liver fibrogenesis. Several
plant-drived antioxidants, such as silymarin, baicalin, beicalein, quercetin, apigenin, were shown to interfere with liver
fibrogenesis. The antioxidans above are polyphenols, flavonoids or structurally related compounds which are the main
chemical components of Pomegranate peels and seeds, and the antioxidant activity of Pomegranate peels and seeds
have been verified. Here we investigated whether the extracts of pomegranate peels (EPP) and seeds (EPS) have
preventive efficacy on liver fibrosis induced by carbon tetrachloride (CCl4) in rats and explored its possible mechanisms.
Methods: The animal model was established by injection with 50 % CCl4 subcutaneously in male wistar rats twice a
week for four weeks. Meanwhile, EPP and EPS were administered orally every day for 4 weeks, respectively. The
protective effects of EPP and EPS on biochemical metabolic parameters, liver function, oxidative markers, activities of
antioxidant enzymes and liver fibrosis were determined in CCl4-induced liver toxicity in rats.
Results: Compared with the sham group, the liver function was worse in CCl4 group, manifested as increased levels of
serum alanine aminotransferase, aspartate aminotransferase and total bilirubin. EPP and EPS treatment significantly
ameliorated these effects of CCl4. EPP and EPS attenuated CCl4–induced increase in the levels of
TGF-β1, hydroxyproline, hyaluronic acid laminin and procollagen type III. They also restored the decreased superoxide
dismutase (SOD), glutathione peroxidase (GSH-Px) activities and inhibited the formation of lipid peroxidized products in
rats treated with CCl4.
Conclusion: The EPP and EPS have protective effects against liver fibrosis induced by CCl4, and its mechanisms might
be associated with their antioxidant activity, the ability of decreasing the level of TGF-β1 and inhibition of collagen
synthesis.
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Background
Liver fibrosis which is a common feature of the ma-
jority of chronic liver diseases is considered as an im-
portant medical problem due to its high morbidity
and mortality [1, 2]. Hepatitis viral infections are the
most common cause, and drug abuse, autoimmune
disorders, biliary obstruction and metabolic disorders
due to mineral overload are also contributed to the
disease [3, 4], which is characterized as excessive ac-
cumulation of collagen and extracellular matrix pro-
teins within the perisinusoidal space [5, 6]. Advanced
liver fibrosis could leads to cirrhosis and liver failure
eventually. Now there is few effective medical treat-
ments approaches for liver fibrosis [6].
The pathogenesis of liver fibrosis remains elusive.
Oxidative stress is recognized as a fundamental factor
in the pathological changes observed in various liver
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diseases [7, 8]. Free radicals, formed as a result of
oxidation, attack the unsaturated fatty acids of bio-
membranes, which results in peroxidation and de-
struction of protein and DNA, leading to various liver
injuries [9]. Several lines of evidence have recently
suggested that oxidative stress plays a pivotal role in
the pathogenesis of liver fibrosis [10]. Antioxidants
are effective for preventing liver fibrogenesis [11–13].
Pomegranate belongs to the Punicagranatum L.,
and is widely cultivated in India, Southeast Asia,
Malaya, the East Indies, tropical Africa and China
[14, 15]. As in the earlier study, pomegranate had
been used as an anthelmintic and antidiarrheal agent.
Recently, the antioxidant activity of pomegranate is
more and more being paid attention [16]. Pomegran-
ate contains large amounts of polyphenols and fla-
vonoid, so that the antioxidant capacity are obvious
among in pomegranate fruit, juice and peel [17–20].
There is growing evidence that EPP have effective ef-
fect against liver fibrosis in rats. Experimental
observations indicated that punicagranatum peel
methanolic extract reversed thioacetamide-induced
liver fibrosis, and significantly decreased the activity
of liver enzymes, bilirubin and serum hepatocyte
growth factor levels. These effects could be attributed
to its antioxidant properties, antifibrotic and antia-
poptotic activity [21]. Tokluet al. have also found
that EPP prevents liver fibrosis in biliary-obstructed
rats, and forecasted EPP’s antioxidant and antifibrotic
properties, may be of potential therapeutic value in
protecting the liver from fibrosis and oxidative injury
due to biliary obstruction [22]. However, the antifi-
brotic effect of EPS on chronic liver diseases has not
been published in the literature. In this study, we
aimed to investigate the effect of EPP and EPS on




Carbon tetrachloride (CCl4) was purchased from
Sigma (St. Louis,MO, USA). Commercial kits for as-
partate aminotransferase (AST), alanine aminotrans-
ferase (ALT), total bilirubin (T-Bil), malondialdehyde
(MDA), glutathione peroxidase (GSH-Px), and super-
oxide dismutase (SOD), as well as hydroxyprolinewere
purchased from Jiancheng Biotechnology Company
(Nanjing, China). The hyaluronic acid (HA), Laminin
(LN), and procollagen type III (PC III) radioimmuno-
assay kits were purchased from Beijing North Instir-
ute of Biotechnology (Beijing, China). Transforming
growth factor-β1 (TGF-β1) was purchased from
Shanghai Huole Institute of Biotechnology (Shanghai,
China). Allother chemicals and reagents used in this
study were of analyticalgrade.
The extracts of pomegranate peels and seeds preparation
Fresh pomegranate fruits were collected in September to
October, 2011 from a natural habitat in Shannxi, China.
Then the pomegranate peels and seeds were artificially
isolated and cleaned, air-dried. The dried pomegranate
peels and seeds were grinded to coarse powder and
passed through the 60 mesh screen, respectively. The
above materials and methods were authenticated by
Professor Qiang Wang who works at Department of
Chinese Materia Medica Analysis, China Pharmaceutical
University, Nanjing, where a voucher specimen has been
deposited (2011–09).
The EPP and EPS were prepared following the method
described previously with some modification [23]. The 3
kilogramme pomegranate peel powder and the 2 kilo-
gramme pomegranate seed powder were extracted with
50 % ethanol in triplicate at 85 °C, respectively. The ex-
tracts were then filtered and evaporate under vacuum
until dried. The dried EPP and EPS were stored in a
refrigerator.
Animals
The forty male wistar rats aged 6–8 weeks old and
weighed 180–200 g purchased from the Experimental
Animal Center Jiaotong University. Rats were housed in
plastic cages (five rats per cage) at 24 °C and 60 % hu-
midity with a 12 h-12 h light–dark cycle and ad libitum
access to water and standard rat chow. The study proto-
col was approved by the Ethics committee of the Xi’an
Jiaotong University Health Science Center. Animal
handling and care was carried out throughout the ex-
periment following international laboratory animal use
and care guidelines (NIH publication no. 85–23,
revised1996).
Experimental model and drug treatment
In this experiment, the rats were randomly divided into
four groups, each of whom has ten rats. (1) Sham group
(sham), in which rats were subcutaneously injected with
vegetal oil without CCl4 (1 mg/kg body weight, twice a
week for four weeks; (2) CCl4 group (CCl4), in which
rats were subcutaneously injected with 50 % CCl4 mixed
with vegetal oil (1 mL/kg body weight) [24, 25]; (3) CCl4
+ EPP group (CCl4 + EPP), in which rats were adminis-
tered with EPP (150 mg/kg body weight) intragastrically
every day for 4 weeks at the same time subjected to
CCl4 and (4) CCl4 + EPS group (CCl4 + EPS), in which
rats were administered EPS (100 mg/kg body weight)
intragastrically every day for 4 weeks at the same time
subjected to CCl4. At 24 h after the final injection of
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CCl4, all rats were anaesthetized with diethyl ether, and
the blood samples were collected from the orbital veins.
The serum samples were obtained by centrifugation of
blood at 3000 rpm for 15 min and were kept frozen at
−80 °C until assayed as described below. After the rats
were killed, the livers and spleen were immediately re-
moved, rinsed in ice-cold saline and weighed. A portion
of each liver was fixed in 10 % formalin for histological
analyses, and the remaining tissues were stored at −80 °C
until required.
Liver index and spleen index
Relative weights of liver and spleen were expressed as
the percentage of the body weight respectively.
Biochemical metabolic parameters
Assessment of liver function
The serum activities of AST and ALT were evaluated by
spectrophotometry using commercially available kits ac-
cording to the manufacturer's instructions; The levels of
HA, LN and PC III were determined using radioimmuno-
assay kits according to the manufacturer’s instructions;
TGF-β1 level in serum was deternined by using rat
enzyme-linked immunosorbent assay (ELISA) kit.
Assessment of oxidative stress and enzymatic antioxidant
status
The tissue homogenates (10 %, w/v) of livers were used
in determination of MDA, SOD and GSH-Px levels ac-
cording to the instructions.
Assessment of collagen
Liver collagen concentration was determined by measur-
ing Hydroxyproline level according to the method de-
scribed previously [1].
Histological observation
Rat livers were carefully isolated and fixed with 10 % for-
malin solution for 24 h. Fixed tissues were dehydrated
and embedded in paraffin and then cut into 5 μm sec-
tions with a Leica RM2135 (Leica, Bensheim, Germany)
for staining. Sections were stained with Hematoxylin-
eosin staining (HE) to observe liver injury, stained with
Masson staining to detect collagen deposition and
stained with Sirius red stain to measure the collagen
content and type. The pathological changes were
assessed and photographed with an Nikon, Japan micro-
sco Liver fibrosis equipped with digital camera (Nikon,
Japan) or polarization microscope (Nikon, Japan). was
graded according to the following scoring system as fol-
lowing [26]: 0, no fibrosis, normal liver and absence of
fibrosis; I, fibrosis present (collagen fiber present that ex-
tends from portal triad or central vein to peripheral re-
gion); II, mild fibrosis (mild collagen fiber present with
extension without compartment formation); III, moder-
ate fibrosis (moderate collagen fiber present with some
pseudo lobe formation) and IV, severe fibrosis (severe
collagen fiber present with thickening of the partial com-
partments and frequent pseudo lobe formation).
Statistical analysis
Quantitative data was expressed as the mean ± S.D. The
significance of the difference versus the CCl4 group was
determined by a Student’s t-test. A Mann-Whitney rank
sum test was used for the analysis of degree of histo-
pathological liver fibrosis. P < 0.05 was considered to be
statistically significant.
Results
The effects of extracts on body weight, liver and spleen
index
The effects of EPP and EPS on the rats’ body weight
were evaluated. Rats were subcutaneously injected with
CCl4, twice a week for four weeks. The body weight gain
were statistically reduced compared with the sham group
(92.74 ± 18.61 vs. 141.09 ± 12.72 g, P < 0.05, n = 10). Pre-
treatment with either EPP or EPS increase the final body
weights of rats to 308.22 ± 19.44 g and 309.10 ± 20.72 g
respectively. Their body weight gain were higher than
CCl4 group (128.30 ± 24.50 and 125.10 ± 22.09 g, vs.
CCl4 group, P < 0.05, n = 10, Table 1).
Subsequently, the liver and spleen index were calcu-
lated as the percentage of the body weight. The results
showed that the liver and spleen index in CCl4 group
were significantly higher than the sham group (5.97 ±
0.49 and 0.50 ± 0.055 % vs. 2.75 ± 0.42 and 0.25 ±
0.035 %, P < 0.05, n = 10). While fed with the EPP and
EPS, these indexes were significantly lower than the
CCl4 group (EPP: 3.58 ± 0.63 and 0.36 ± 0.055 %; EPS:
3.55 ± 0.55 and 0.35 ± 0.039 %, vs. CCl4 group, P < 0.05,
n = 10, Table 1).
The effects of extracts on liver function
The significantly higher levels of ALT, AST and T-Bil
in the serum of the rats in the CCl4 group were ex-
hibited than that of the sham group (ALT: 121.17 ±
21.24 vs. 33.70 ± 6.04 U/L; AST: 169.20 ± 22.15 vs.
55.31 ± 6.22 U/L; T-Bil: 9.25 ± 0.66 vs. 3.07 ± 0.98 mol/
L, respectively; P < 0.01, n = 10). EPP and EPS treat-
ment efficiently reduced the ALT level to 88.50 ±
11.62 and 89.62 ± 11.01 U/L (P < 0.05, n = 10, Fig. 1a),
decreased the AST to 124.90 ± 24.90 and 126.33 ±
18.84 U/L (P < 0.05, n = 10, Fig. 1b), and also signifi-
cantly suppressed CCl4–induced increase in T-Bil
level (4.73 ± 1.09 and 5.51 ± 1.20 mol/L, P < 0.05, n = 10,
Fig. 1c). The result indicated that the EPP and EPS
had protective effects against liver injuries in rats
injected with CCl4.
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The effects of extracts on the microstructure of liver
The effects of EPP and EPS on the microstructure
changes of liver were shown in Fig. 2. The results of HE
staining indicated that CCl4 administration presented
extensive changes in liver morphology, including marked
enlarged areas of hepatocellular degeneration and infil-
tration inflammatory cells. No histological abnormalities
were observed in sham group. EPP and EPS treatment
significantly alleviated the degree of liver injury.
The EPP and EPS attenuates CCl4-induced liver fibrosis
Further, the effects of EPP and EPS on the markers of
liver fibrosis were examined. As shown in Fig. 3a, the
level of TGF-β1 in CCl4 group was elevated significantly
compared to that of the sham group (38.27 ± 5.37 vs.
11.14 ± 1.39 μg/L, P < 0.01, n = 10). EPP and EPS signifi-
cantly decreased the TGF-β1 level in serum compared to
that of the CCl4 group (25.00 ± 2.67 and 26.29 ± 2.95 μg/
L,P < 0.05, n = 10).
Hydroxyproline content in liver and serum levels of
HA, LN and PC III as the indexes of liver fibrosis were
tested. It is shown that CCl4 significantly increased hy-
droxyproline, HA, LN and PC III compare with that of
the sham group (hydroxyproline: 2.81 ± 0.33 vs. 1.13 ±
0.18 mg/g; HA: 239.38 ± 32.80 vs. 92.08 ± 22.77 μg/L;
LN: 253.85 ± 36.47 vs. 99.54 ± 24.63 μg/L and PC III:
256.26 ± 31.40 vs. 92.17 ± 18.48 μg/L, P < 0.01, n = 10).
EPP and EPS had potential for the reduction of hydroxy-
proline, HA, LN and PC III level that increased by CCl4.
The final values were hydroxyproline: 2.12 ± 0.28 and
2.17 ± 0.30 mg/g; HA: 168.64 ± 26.61 and 170.98 ±
31.11 μg/L; LN: 183.77 ± 31.12 and 186.17 ± 31.95 μg/L;
PC III: 165.77 ± 19.30 and 174.30 ± 24.93 μg/L (P < 0.05,
n = 10, fig B-E).
The effects of extracts on liver fibrosis histological
examination
Liver fibrosis was evaluated histologically using Masson
staining and Sirius red staining in the different groups.
The Masson staining showed that the normal hepatic
lobules in CCl4 group were disappeared, collagen was
deposited and pseudo lobule was formed. Treatment
with EPP and EPS obviously alleviated the collagen de-
position. Fig. 4b showed that treatment with EPP and
EPS significantly lower the graded of fibrosis as com-
pared to CCl4 group (P < 0.01, P < 0.05, n = 10).
Sirius red stains collagen red on a pale yellow back-
ground in brightfield microscope, whereas under
polarization microscope the typeI collagen appears bright
orange-red and the type III collagen appears bright yellow-
green. Sirius red staining showed that in CCl4 group, type I
and III collagen were more than that of the sham group,
and treatment with EPP and EPS could effectively against
the increase in type I and III collagen induced by CCl4
(P < 0.01, P < 0.05, n = 10, Fig. 4c).
Table 1 Initial body weight, final body weight, body weight gain, liver index and spleen index in differente experimental groups






Sham 180.41 ± 14.31 321.50 ± 18.49 141.09 ± 12.72 2.75 ± 0.42 0.25 ± 0.035
CCl4 179.66 ± 10.10 272.40 ± 21.03 92.74 ± 18.61* 5.97 ± 0.49
* 0.50 ± 0.055*
CCl4 + EPP 180.82 ± 9.28 308.22 ± 19.44 128.30 ± 24.50
# 3.58 ± 0.63# 0.36 ± 0.055#
CCl4 + EPS 184.00 ± 10.98 309.10 ± 20.72 125.10 ± 22.09
# 3.55 ± 0.55# 0.35 ± 0.039#
EPP (150 mg/kg) and EPS (100 mg/kg) were administered orally for 4 weeks. The values are expressed as the mean ± S.D. (n = 10).*P < 0.05, compared with the
sham group, #P < 0.05, compared with the CCl4 group
Fig. 1 Effects of EPP and EPS on serum of ALT (a), AST (b) and T-Bil (c) after CCl4 injury. **P < 0.01, vs. sham group;
#P < 0.05, vs. CCl4 group; n = 10
in each group; values are mean ± S.D
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The effects of extracts on hepatic MDA, SOD and GSH-Px
activities
As expected, the treatment with EPP and EPS also
showed effective anti-oxygenation in CCl4 injury rats.
MDA levels, and the end product of lipid peroxidation,
were significantly higher in the CCl4 group than in the
sham-operated group (P < 0.05). In the EPP and EPS
treated groups, hepatic MDA levels were markedly de-
creased compared with that of the CCl4 group (EPP:
50.21 ± 10.23 vs. 71.10 ± 12.63 μmol/g; EPS: 50.84 ±
11.05 μmol/g, P < 0.05, n = 10, Fig. 5a).
Meanwhile, thehepatic SOD and GSH-Pxactivities
were lower in the CCl4 group than in the sham-operated
group (P < 0.01). EPP and EPS treatment both efficiently
increased the SOD activities from 133.47 ± 28.29 U/mg
in the CCl4 group to 185.72 ± 30.05 U/mg in the EPP
group and 187.94 ± 21.38 U/mg in the EPS group
(P < 0.05, n = 10, Fig. 5b). They also efficiently increased
the GSH-Pxactivities from 252.07 ± 39.39 U/mg in the
CCl4 group to 355.73 ± 41.88 U/mg in the EPP group and
349.47 ± 40.10 U/mg in the EPS group (P < 0.05, n = 10,
Fig. 5c).
Fig. 2 Effects of EPP and EPS on the microstructure of CCl4 injury liver. HE staining analysis of hepatic histological abnormalities showing
hepatocellular degeneration (blue arrowheads), infiltration inflammatory cells (red arrowheads) and vacuolated cells (black arrowheads)
Fig. 3 Effects of EPP and EPS onserum of TGF-β1 (a), HA (c), LN (d), PC III (e) and liver of hydroxyproline (b) after CCl4 injury.**P < 0.01, vs.
sham group; #P < 0.05, vs. CCl4 group; n = 10 in each group; values are mean ± S.D
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Discussion
The aim of this study is to evaluate the protective ef-
fects of the extracts of the pomegranate peels and
seeds against liver fibrosis induced by CCl4 in rats.
The study showed that EPP and EPS treatment ap-
peared to be beneficial in this animal model of CCl4
injury in terms of reduced liver index and spleen
index, improved liver function, and inhibited the de-
velopment of hepatic fibrosis rats. These protective
effects may depend on decreased MDA levels and in-
crease SOD and GSH-Px activities, which implied
anti-oxygenation activity may be the possible mechan-
ism of EPP and EPS in abrogating liver fibrosis.
CCl4 treatment is frequently used in rats to produce
an experimental model to study liver fibrosis [27, 28]. In
the present study, liver fibrosis was successfully induced
by subcutaneous injection of 50 % CCl4 for a period of
4 weeks. The histological results showed that the normal
structure of lobules was destroyed and pseudolobules
formed. Moreover, the increased hydroxyproline content
in liver and serum HA, LN and PC III also confirmed
the liver fibrosis in rats.
Fig. 4 Effect of EPP and EPS on histological morphology of fibrosis rat liver with Masson and Sirius red staining. a: Masson and Sirius red
staining analysis of hepatic fibrosis (arrows); b: the graded of fibrosis with Masson staining; c: the type and graded of fibrosis with Sirius red
staining.**P < 0.01, vs. sham group; ##P < 0.01,#P < 0.05, vs. CCl4 group; n = 10 in each group; values are mean ± S.D
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The increased levels of aminotransferases are the re-
sults of leakage from damaged hepatic cells and are used
as markers of liver injury [29]. It was shown in this study
that abnormal aminotransferase activity was noted in
rats injected with CCl4 and were decreased by adminis-
tration of the EPP and EPS. These results provided evi-
dence that the EPP and EPS are able to improve hepatic
steatosis in rats without obvious hepatotoxicity. The
hepato protective effects of EPP and EPS were further
evidenced by marked improvement in the histopatho-
logical examination.
Proteins HA, LN and PC III are important biomarkers
of hepatic fibrogenesis [30, 31]. Hydroxyproline in liver
is an important index whose level reflects the amount of
collagen and therefore it can be used to determine the
extent of fibrosis [32]. Thus, HA, LN, PC III and hy-
droxyproline are important indexes to appraisal liver fi-
brosis. The result in this study showed that EPP and EPS
could significantly decrease HA, LN and PC III in serum
and hydroxyproline content in liver, which suggested
that EPP and EPS can inhibit collagen deposition in
liver.
Being recognized as a major profibrogenic cytokine
in the progression of liver fibrosis, TGF-β1 is respon-
sible for hepatic stellate cells (HSCs) activation and
migration which is supposed to be the central event
of liver fibrosis [33, 34]. It has been reported that
anti-TGF-β1 antibody ameliorated concanavalin A-
induced liver fibrosis, while over-expression of TGF-
β1 in transgenic mice resulted in the acceleration of
liver fibrosis progression [35, 36]. The overexpression
of TGF-β1 has been correlated with the degree of fi-
brosis in both animal models and human diseases.
The results in this study showed that EPP and EPS
decreased the serum levels of TGF-β1, which sug-
gested that these extracts may be associated with the
regulation of cytokine release.
It has been proved that oxidative stress plays an im-
portant role in the generation of CCl4-induced liver
fibrosis [37–39]. CCl4 can be metabolized by cytochrome
P450 in liver cells after being injected into rats, and
eventually yield the trichloromethyl-free radical. These
compounds trigger a cascade of reactions and lipid per-
oxidation, which lead to cell injury and chronic liver in-
jury with the result of liver fibrosis [40]. MDA is the
main product of lipid peroxidation and its concentration
is generally presented as the total level of lipid peroxida-
tion products [41]. SOD and GSH-Px are key enzymes
in antioxidant defense system, and they can catalyze the
transformation of hydrogen peroxide into water [42–44].
The results in this study demonstrated that CCl4 led to
increases of MDA levels and decreases of SOD and
GSH-Px levels in the liver. Administration of EPP and
EPS increased SOD and GSH-Px activity, while
depressed MDA production in hepatic tissues in rats
treated with CCl4. These results indicated that the pro-
tective effects of EPP and EPS on liver fibrosis were
partly due to their antioxidant activities.
Additionally, this study showed that EPP and EPS af-
fected the protective action on liver injury and antioxi-
dant state. These resulte are probably attributed to its
phenolic compounds and linolenic acid contained in this
fruit. EPP mainly contain total phenolics, including
mainly hydrolyzable tannins (ellagitannins), such as olig-
omers and punicalagin/punicalin. Nevertheless, EPS
mainly contain fatty acids (eg. punicic acid, linolenic acid
isomers, linoleic, palmitic and stearic, et al.), no pheno-
lics are present [22]. The antioxidant activity of pheno-
lics and linolenic acid are mainly due to their redox
properties, which allow them to act as reducing agents,
hydrogen donors, singlet oxygen quenchers, and metal
chelators [22, 45].
Conclusions
In conclusion, pomegranate is a high nutritious and de-
sirable fruit with rich bioactive profile. Because of its
beneficial physiological activities, the consumption of
pomegranate has grown tremendously. The present
Fig. 5 Effects of EPP and EPS on MDA level (a), SOD (b) and GSH-Px (c) activities in liver homogenates of liver fibrosis rats. **P < 0.01,*P < 0.05 vs.
sham group;#P < 0.05, vs. CCl4 group; n = 10 in each group; values are mean ± S.D
Wei et al. BMC Complementary and Alternative Medicine  (2015) 15:389 Page 7 of 9
study showed that pomegranate peels and seeds have
preventive effects against liver fibrosis. The main mecha-
nisms of the effects might be related to its antioxidant
activity, decreased the level of TGF-β1 and inhibition of
collagen synthesis. However, further studies are required.
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